Increased Risk of Venous Thromboembolism and Death from Stroke

  • Increased risk of deep vein thrombosis and pulmonary embolism have been reported with this drug.
  • Women with active or past history of venous thromboembolism should not take this drug.
  • Increased risk of death due to stroke occurred in a trial in postmenopausal women with documented coronary heart disease or at increased risk for major coronary events. Consider risk-benefit balance in women at risk for stroke.

Patient counseling

Medical guidelines

Package inserts

Additional information

Updated: January 2018